| Literature DB >> 22074783 |
Luciana L Molinero1, Maria-Luisa Alegre.
Abstract
Nuclear factor (NF) κB is a pleiotropic transcription factor that is ubiquitously expressed. After transplantation of solid organs, NF-κB in the graft is activated within a few hours as a consequence of ischemia/reperfusion and then again after a few days in intragraft infiltrating cells during the process of acute allograft rejection. In the present article, we review the components of the NF-κB pathway, their mechanisms of activation, and their role in T cell and antigen-presenting cell activation and differentiation and in solid organ allograft rejection. Targeted inhibition of NF-κB in selected cell types may promote graft survival with fewer adverse effects compared with global immunosuppressive therapies.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22074783 PMCID: PMC3309102 DOI: 10.1016/j.trre.2011.07.005
Source DB: PubMed Journal: Transplant Rev (Orlando) ISSN: 0955-470X Impact factor: 3.943